Clinical outcome of a cohort of 63 patients with hepatocellular carcinoma treated with octreotide

Zeitschrift fur Gastroenterologie

Volumn 40, Issue 6, 2002, Pages 395-400

  Rabe, C ^a   Pilz, T ^a   Allgaier, H P ^a   Halm, U ^a   Strasser C ^a   Wettstein, M ^a   Sauerbruch, T ^a   Caselmann, W H ^a  

^a NONE   (Germany)

Author keywords

Cirrhosis; Hepatocellular carcinoma; Liver transplantation; Octreotide; Prognosis

Indexed keywords

OCTREOTIDE;

ABDOMINAL PAIN; ADULT; AGED; ALCOHOL ABUSE; ARTICLE; BILIARY TRACT DISEASE; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COHORT ANALYSIS; DIARRHEA; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG EFFECT; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; GERMANY; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; MULTICENTER STUDY; OUTCOMES RESEARCH; RETROSPECTIVE STUDY; SLOW RELEASE FORMULATION; SURVIVAL TIME; VIRUS HEPATITIS;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; OCTREOTIDE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0036075449     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-32129     Document Type: Article

References (24)

1. Rising incidence of hepatocellular carcinoma in the United States
2. Risk factors for the rising rates of primary liver cancer in the United States
3. Interaction of Hepatitis B virus with cellular processes in liver carcinogenesis
4. Hepatitis C virus infection as a major risk factor for hepatocellular carcinoma
5. Hepatocellular carcinoma in Germany: A retrospective epidemiological study from a low-endemic area
6. Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma
7. Hepatozelluläres karzinom in Deutschland. Epidemiologie, atiologie, klinik und prognose bei 100 konsekutiven patienten einer Universitätsklinik
8. Leberzirrhose - Teil 1: Pathogenese und diagnostik
9. Hepatocellular carcinoma in Central Europe: Prognostic features and survival
10. Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection - A single-center analysis including 132 patients
11. Laser-induced thermotherapy of malignant liver tumors: General principals, equipment(s), procedure(s) side effects, complications and results. Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: Technique and prospective results
12. Percutaneous ethanol injection under general anesthesia for hepatocellular carcinoma: 3 Year survival in 112 patients
13. Treatment of hepatocellular carcinoma with octreotide: A randomised controlled study
14. Treatment of hepatocellular cancer with the long acting somatostatin analog lanreotide in vitro and in vivo
15. Therapiestudie des hepatozellulären karzinoms mit octreotid ("HECTOR")
16. Intraarterial HCC therapy with 1-131-Lipiodol
17. Reporting results of cancer treatment
18. Successful treatment of an advanced hepatocellular carcinoma with the long-acting somatostatin analog lanreotide
19. Hepatocellular carcinoma in Austria: Aetiological and clinical characteristics at presentation
20. Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: A prospective randomized study
21. Randomized control trials on chemoembolization for hepatocellular carcinoma: Is there room for new studies?
22. Tamoxifen does not improve survival of patients with advanced hepatocellular carcinoma
23. Regulatory peptide receptors in human hepatocellular carcinomas
24. Apoptosis is induced in both drug-sensitive and multidrug-resistant hepatoma cells by somatostatin analogue TT-232